Cargando…
New Recommendation on Biological Materials Could Hamper Muscular Dystrophy Research
The new ‘Recommendation of the Committee of Ministers to member States on research on biological materials of human origin’, adopted in Europe in May 2016 is confusing and lacks specificity on the research use of biomaterials taken from persons not able to consent. It is possible to interpret the re...
Autores principales: | McCormack, Pauline, Woods, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233593/ https://www.ncbi.nlm.nih.gov/pubmed/28133562 http://dx.doi.org/10.1371/currents.md.f21a7be89ed7fcdc689bf30e97dd2756 |
Ejemplares similares
-
The proteasomal inhibitor MG132 prevents muscular dystrophy in zebrafish
por: Winder, Steve J, et al.
Publicado: (2011) -
Health Care Transition Experiences of Males with Childhood-onset Duchenne and Becker Muscular Dystrophy: Findings from the Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet) Health Care Transitions and Other Life Experiences Survey
por: Paramsothy, Pangaja, et al.
Publicado: (2018) -
Investigating Synthetic Oligonucleotide Targeting of Mir31 in Duchenne Muscular Dystrophy
por: Hildyard, John CW, et al.
Publicado: (2016) -
Clinic-Based Infant Screening for Duchenne Muscular Dystrophy: A Feasibility Study
por: Cyrus, Alissa, et al.
Publicado: (2012) -
A Pilot Survey Study of Adherence to Care Considerations for Duchenne Muscular Dystrophy
por: Conway, Kristin, et al.
Publicado: (2018)